Can Antipsychotic Doses Be Reduced Safely?

The Psychopharmacology Institute is an online platform offering unbiased, practical psychopharmacology updates for healthcare providers, with content updated monthly. It also presents opportunities to earn CME and SA credits.
In this Quick Take, Dr. Oliver Freudenreich discusses the findings of the RADAR study, a clinical antipsychotic dose reduction trial for schizophrenia. The study found that although dose reduction or discontinuation of antipsychotics did not improve psychosocial function, it did double the relapse risk in patients with remitting, relapsing psychotic illness.
Find the transcript of this section here: psychopharmacologyinstitute.c...
Did we mention you can also earn CME credits? This is something that you can take advantage of as a Silver or Gold member. Want to know more about Quick Takes and memberships? Click here: psychopharmacologyinstitute.c...
#AntipsychoticDoseReduction #SchizophreniaResearch #PsychosisRelapseRisk #psychopharmacology

[@nickdark817]

Well done